Mineralocorticoid receptor antagonists

Intervention3 papers1 finding

Humans1

Outcomes

1

Cardiovascular and renal outcomes

upin humans1

1 study

Mineralocorticoid receptor antagonists improve cardiovascular and renal outcomes in humans.
Reviewin patients with HFpEF
Heart failure with a preserved ejection fraction: synergy between cardiac and extracardiac mechanisms and effects of novel therapies · Heart failure reviews · 21 Sep 2026

Latest

3

MedicinaReview28 Sep

Cardiovascular-Kidney-Metabolic Syndrome and Its Hepatic Dimension: A Narrative Review

Heart Failure ReviewsReview21 Sep

Heart failure with a preserved ejection fraction: synergy between cardiac and extracardiac mechanisms and effects of novel therapies

Heart failure with preserved ejection fraction

EClinicalMedicineHumans6 Sep

Comparative effectiveness of GLP-1 receptor agonists versus mineralocorticoid receptor antagonists as fourth-line pharmacological therapy in patients with resistant hypertension and overweight or obesity: a retrospective multicenter cohort study in the USA

GLP-1 receptor agonists